Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
46.94
-1.72 (-3.53%)
At close: Mar 6, 2026, 4:00 PM EST
46.64
-0.30 (-0.63%)
After-hours: Mar 6, 2026, 7:57 PM EST
Twist Bioscience Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Twist Bioscience stock have an average target of 48.75, with a low estimate of 33 and a high estimate of 79. The average target predicts an increase of 3.86% from the current stock price of 46.94.
Analyst Consensus: Buy
* Price targets were last updated on Feb 3, 2026.
Analyst Ratings
The average analyst rating for Twist Bioscience stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 3 | 3 | 3 |
| Buy | 5 | 6 | 5 | 5 | 5 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 8 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $42 → $52 | Buy | Maintains | $42 → $52 | +10.78% | Feb 3, 2026 |
| Barclays | Barclays | Buy Maintains $39 → $50 | Buy | Maintains | $39 → $50 | +6.52% | Feb 3, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $77 → $79 | Strong Buy | Maintains | $77 → $79 | +68.30% | Jan 26, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $32 → $43 | Strong Buy | Maintains | $32 → $43 | -8.39% | Jan 8, 2026 |
| Barclays | Barclays | Buy Maintains $37 → $39 | Buy | Maintains | $37 → $39 | -16.92% | Dec 15, 2025 |
Financial Forecast
Revenue This Year
447.71M
from 376.57M
Increased by 18.89%
Revenue Next Year
516.11M
from 447.71M
Increased by 15.28%
EPS This Year
-1.84
from -1.30
EPS Next Year
-1.33
from -1.84
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 462.0M | 539.9M | |||
| Avg | 447.7M | 516.1M | |||
| Low | 428.6M | 485.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 22.7% | 20.6% | |||
| Avg | 18.9% | 15.3% | |||
| Low | 13.8% | 8.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.75 | -0.98 | |
| Avg | -1.84 | -1.33 | |
| Low | -1.93 | -1.69 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.